New injection offers hope for men with chronic groin pain

NCT ID NCT05707208

Completed Symptom relief Sponsor: Sustained Therapeutics Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new drug called ST-01, given as a shot into the spermatic cord every 28 days, to see if it safely reduces chronic scrotal pain better than standard lidocaine. 63 men with pain lasting over 3 months took part. The main goal was to measure pain changes using a 0-10 scale over 56 days.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC PAIN

Contacts and locations

Locations

Jonathan Giddens Medicine Professional Corporation

Brampton, Ontario, L6T 4S5, Canada
Kelowna General Hospital Clinical Research Department

Kelowna, British Columbia, V1Y 1T2, Canada
Men's Health Clinic Manitoba

Winnipeg, Manitoba, R3P 2S8, Canada
Mount Sinai Hospital - Men's Health Institute

Toronto, Ontario, M5T 3L9, Canada
Prostate Cancer Centre - Rockyview Hospital

Calgary, Alberta, T2V 1P9, Canada
THEO Medical

Montreal, Quebec, H3M 1L3, Canada
The Fe/Male Health Centre

Oakville, Ontario, L6H 3P1, Canada
Vancouver Prostate Centre

Vancouver, British Columbia, V5Z 1M9, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.